These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 618240)

  • 1. [Correlation between platelet aggregation and hyperlipemia. Clinical study].
    Cafiero M; Buono G; Pacileo S; Pirone S; Sensale P
    Boll Soc Ital Cardiol; 1977; 22(7):1042-7. PubMed ID: 618240
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet activity in acute and chronic ischemic cardiopathy].
    Scrobohaci ML; Stăncioiu N; Zătreanu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(3):273-82. PubMed ID: 18783
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum lipids, lipoproteins and coronary disease].
    Nikkilä EA
    Duodecim; 1972; 88(21):1271-82. PubMed ID: 4656210
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative value of triglycerides and cholesterol in the detection of serum hyperlipemia in coronary arteriosclerosis].
    Viciu E; Iacobini P; Niţu S; Balş I
    Med Interna (Bucur); 1971 Aug; 23(8):919-24. PubMed ID: 5093850
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of lipid metabolism disorders].
    Schlierf G
    Internist (Berl); 1984 May; 25(5):275-81. PubMed ID: 6329983
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo platelet activity and lipoprotein patterns in coronary artery disease.
    Goubran F; Maklady F; Saad M; el-Ashry M
    Wien Klin Wochenschr; 1986 Apr; 98(7):209-11. PubMed ID: 3705598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Flotation analysis studies of lipoproteins in correlation with the lipid pattern in essential hyperlipemia and diabetic metabolism status].
    Haller H; Hanefeld H; Kretschmar R; Unger E; Arnold F; Wagner B
    Schweiz Med Wochenschr; 1969 May; 99(22):813-5. PubMed ID: 5802001
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasma glycosaminoglycans in patients with coronary disease and hyperlipidemia].
    Giannini SD; Strunz CM; Forti N; Credidio Rde A; Diament J; Dereviacki BE; de Góis JM; de Serro-Azul LG
    Arq Bras Cardiol; 1986 May; 46(5):307-10. PubMed ID: 3471185
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperlipidemia, lipoproteins and coronary disease.
    Olsson AG
    Acta Cardiol; 1974; Suppl 20():37-45. PubMed ID: 4548621
    [No Abstract]   [Full Text] [Related]  

  • 11. Poor predictability of lipoprotein cholesterol from whole serum lipids.
    Jones RJ; Cohen L; Dobrilovic L
    J Atheroscler Res; 1968; 8(3):463-70. PubMed ID: 5660507
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet activity in acute and chronic ischemic heart disease, with reference to the type of hyperlipoproteinemia.
    Stăncioiu N; Scrobohaci ML; Zătreanu I; Orha I
    Med Interne; 1978; 16(4):395-403. PubMed ID: 749178
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholesterol esterification and net mass transfer of cholesterylesters and triglycerides in plasma from healthy subjects and hyperlipidemic coronary heart disease patients.
    Van Tol A; Scheek LM; Groener JE
    Adv Exp Med Biol; 1988; 243():231-7. PubMed ID: 3223416
    [No Abstract]   [Full Text] [Related]  

  • 14. [Spontaneous variations of lipid fractions in normal and hyperlipidemic patients].
    Forti N; Giannini SD; de Góis JM; Dereviacki BE; de Serro-Azul LG
    Arq Bras Cardiol; 1984 Mar; 42(3):177-81. PubMed ID: 6477188
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum lipoprotein abnormalities in ischaemic heart disease.
    Lewis B; Carlson LA; Mancini M; Micheli H
    Postgrad Med J; 1975; 51(8):37-9. PubMed ID: 1221378
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype.
    Twickler TB; Dallinga-Thie GM; Cohn JS; Chapman MJ
    Circulation; 2004 Apr; 109(16):1918-25. PubMed ID: 15117861
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary hyperlipoproteinemias in patients with coronary disease and peripheral arterial circulatory disorders].
    Klemens UH; Kissling E; von Löwis of Menar P; Schröder R; Bremer A
    Verh Dtsch Ges Inn Med; 1972; 78():1342-6. PubMed ID: 4665541
    [No Abstract]   [Full Text] [Related]  

  • 18. An experimental model of hyperlipemia.
    Samochowiec L
    Acta Biol Med Ger; 1980; 39(7):833-6. PubMed ID: 7211071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate-induced hyperlipemia in human atherosclerosis.
    Avogaro P; Cazzolato G; Pais M; Trabuio G
    Acta Diabetol Lat; 1974; 11(6):479-85. PubMed ID: 4469859
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.